Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Lung Cancer
Related studies linked through entity extraction aliases.
S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Effectiveness of KOS-862 in the Treatment of Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Iscar for Supplemental Care in Stage IV Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
- Status
- COMPLETED
- Phase
- N/A
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3